EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural and Serological Characterization of Yet Another New O Antigen, O86, in Proteus mirabilis Clinical Strains

Dominika Drzewiecka iD, Evgeniya A Levina, Alexander S Shashkov, Nadezhda A Kalinchuk, Yuriy A Knirel

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dominika Drzewiecka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology of Bacteria, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland. Hauptthemen laut MEDLINE: Proteus mirabilis, O Antigens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteria from the genus Proteus are facultative human pathogens, primarily attacking the urinary tract and wounds. A total of 85 O serogroups have been identified so far among these bacilli. P. mirabilis Bprz 86 was isolated from the fistula of a patient in Łódź, Poland. Enzyme-Linked Immunosorbent Assay (ELISA) and Western blotting studies involving the P. mirabilis Bprz 86 lipopolysaccharide (LPS) and the strain-specific rabbit antiserum indicated that the strain, which does not belong to any of the O1–O85 serogroups, shares a common epitope with Proteus O17 antigens and is identical to another clinical P. mirabilis strain, Sm 120, isolated from the urine of a patient in the area. The O-specific polysaccharide (O antigen) was obtained from P. mirabilis Bprz 86 LPS through mild acid degradation, and the six-constituent structure of its repeating unit was determined using chemical analyses and 1D and 2D 1H and 13C Nuclear Magnetic Resonance (NMR) spectroscopy. It includes (R)-3-hydroxybutanoyl, which, along with fucosamine and glucose residues, forms a fragment also present in the O17 antigens. Based on the obtained serological and chemical data, the two studied P. mirabilis isolates were proposed as candidates for a new successive O serogroup in the genus Proteus, O86.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteus mirabilisO AntigensHumansProteus InfectionsLipopolysaccharidesEnzyme-Linked Immunosorbent AssayAnimalsSerogroupRabbits

Stichwörter der Autor:innen

(R)-3-hydroxybutanoic acidO-specific polysaccharidechemical structureepitopelipopolysaccharideserotyping

Substanzen

O AntigensLipopolysaccharides

Autor:innen und Institutionen

  • Department of Biology of Bacteria, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.
  • N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.
  • Higher Chemical College of the Russian Academy of Sciences, D. I. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.

ORCID-Profile: Dominika Drzewiecka

Förderung

  • University of Lodz

Zitieren

APA

Drzewiecka, D., Levina, E. A., Shashkov, A. S., Kalinchuk, N. A., & Knirel, Y. A. (2024). Structural and Serological Characterization of Yet Another New O Antigen, O86, in Proteus mirabilis Clinical Strains. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413642

Vancouver

Drzewiecka D, Levina EA, Shashkov AS, Kalinchuk NA, Knirel YA. Structural and Serological Characterization of Yet Another New O Antigen, O86, in Proteus mirabilis Clinical Strains. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413642

BibTeX
@article{Drzewiecka2024,
  author = {Drzewiecka, Dominika and Levina, Evgeniya A and Shashkov, Alexander S and Kalinchuk, Nadezhda A and Knirel, Yuriy A},
  title = {Structural and Serological Characterization of Yet Another New O Antigen, O86, in Proteus mirabilis Clinical Strains},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413642}
}
Kostenlos starten →